These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3351 related items for PubMed ID: 33297613

  • 21. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ, Advisory Committee on Immunization Practices, Healthcare Infection Control Practices Advisory Committee.
    MMWR Recomm Rep; 2003 Apr 04; 52(RR-7):1-16. PubMed ID: 12710832
    [Abstract] [Full Text] [Related]

  • 22. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.
    Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2007 Jul 13; 56(RR-6):1-54. PubMed ID: 17625497
    [Abstract] [Full Text] [Related]

  • 23. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
    National Center for Immunization and Respiratory Diseases, CDC, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2009 Aug 28; 58(RR-10):1-8. PubMed ID: 19713882
    [Abstract] [Full Text] [Related]

  • 24. Seasonal influenza vaccines.
    Fiore AE, Bridges CB, Cox NJ.
    Curr Top Microbiol Immunol; 2009 Aug 28; 333():43-82. PubMed ID: 19768400
    [Abstract] [Full Text] [Related]

  • 25. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
    Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 2009 Jul 31; 58(RR-8):1-52. PubMed ID: 19644442
    [Abstract] [Full Text] [Related]

  • 26. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR, Lone NI, Kavanagh K, Englishby T, Robertson C, McMenamin J, Wissman BV, Vasileiou E, Butler CC, Ritchie LD, Gunson R, Schwarze J, Sheikh A.
    Health Technol Assess; 2020 Dec 31; 24(67):1-66. PubMed ID: 33256892
    [Abstract] [Full Text] [Related]

  • 27. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.
    Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NS, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2008 Aug 08; 57(RR-7):1-60. PubMed ID: 18685555
    [Abstract] [Full Text] [Related]

  • 28. Recommendations for Prevention and Control of Influenza in Children, 2018-2019.
    COMMITTEE ON INFECTIOUS DISEASES.
    Pediatrics; 2018 Oct 08; 142(4):. PubMed ID: 30177511
    [Abstract] [Full Text] [Related]

  • 29. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM, El Omeiri N, Kurtis HJ, Danovaro-Holliday MC, Ruiz-Matus C.
    Hum Vaccin Immunother; 2016 Aug 02; 12(8):2206-2214. PubMed ID: 27196006
    [Abstract] [Full Text] [Related]

  • 30. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003 Aug 02; 4(5):312-9. PubMed ID: 12952502
    [Abstract] [Full Text] [Related]

  • 31. [Vaccination against influenza in pregnant women - safety and effectiveness].
    Nitsch-Osuch A, Woźniak Kosek A, Brydak LB.
    Ginekol Pol; 2013 Jan 02; 84(1):56-61. PubMed ID: 23488311
    [Abstract] [Full Text] [Related]

  • 32. Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh.
    Hassan MZ, Biswas MAAJ, Rahman M, Shoshi HR, Pyash AS, Islam MA, Haque MA, Parvin SR, Hossen MT, Hussain M, Rahman M, Shirin T, Chowdhury F.
    BMC Public Health; 2024 Jan 20; 24(1):242. PubMed ID: 38245668
    [Abstract] [Full Text] [Related]

  • 33. Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons.
    Lu PJ, Santibanez TA, Williams WW, Zhang J, Ding H, Bryan L, O'Halloran A, Greby SM, Bridges CB, Graitcer SB, Kennedy ED, Lindley MC, Ahluwalia IB, LaVail K, Pabst LJ, Harris L, Vogt T, Town M, Singleton JA, Centers for Disease Control and Prevention (CDC).
    MMWR Surveill Summ; 2013 Oct 25; 62(4):1-28. PubMed ID: 24157710
    [Abstract] [Full Text] [Related]

  • 34. Recommendations for prevention and control of influenza in children, 2014-2015.
    Committee On Infectious Diseases, American Academy Pediatrics.
    Pediatrics; 2014 Nov 25; 134(5):e1503-19. PubMed ID: 25246619
    [Abstract] [Full Text] [Related]

  • 35. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 2008 Apr 25; 121(4):e1016-31. PubMed ID: 18381500
    [Abstract] [Full Text] [Related]

  • 36. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T, Kirstein J, Devota Go G, Leav B, Ruzycky ME, Isakov L, de Bruijn M, Oberye J, Heijnen E.
    Lancet Respir Med; 2018 May 25; 6(5):345-356. PubMed ID: 29631857
    [Abstract] [Full Text] [Related]

  • 37. An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.
    Ng S, Wu P, Nishiura H, Ip DK, Lee ES, Cowling BJ.
    BMC Infect Dis; 2011 Aug 26; 11():230. PubMed ID: 21871096
    [Abstract] [Full Text] [Related]

  • 38. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 26; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
    Brogan AJ, Talbird SE, Davis AE, Thommes EW, Meier G.
    Hum Vaccin Immunother; 2017 Mar 04; 13(3):533-542. PubMed ID: 27780425
    [Abstract] [Full Text] [Related]

  • 40. Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.
    Salamanca de la Cueva I, Cinconze E, Eckermann T, Nwoji U, Godderis L, Lu E, Martínez-Gómez X, Wang H, Yanni E.
    Drug Saf; 2021 Dec 04; 44(12):1375-1390. PubMed ID: 34694589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 168.